Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14
The purpose of this study is the safety and efficacy of Burprenorphine/Naloxone in the treatment of opioid dependence. A compassionate use study.
|Study Design:||Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Buprenorphine/Nx Treatment of Heroin Dependence-A Compassionate Use Study|
- Opioid withdrawal
- Subjective rating
|Study Start Date:||November 1997|
The objective of this study is to provide follow-up compassionate use treatment and evaluate long term safety and efficacy of a buprenorphine/naloxone combination tablet for opiate dependence treatment for subjects who have completed CS 1008 A and B.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00015340
|United States, New York|
|New York VAMC|
|New York, New York, United States, 10010|
|Principal Investigator:||Paul Casadonte, M.D.||New York VAMC|